Chemours (CC) Non Operating Interest Expenses (2015 - 2026)

Chemours has reported Non Operating Interest Expenses for 12 years, with the latest figure at $68.0 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 1.49% year-over-year to $68.0 million in Q2 2026; TTM through Jun 2026 was $273.0 million, a 1.87% increase from a year earlier, with the FY2025 full-year figure at $269.0 million, up 2.28% from the prior year.
• Non Operating Interest Expenses was $68.0 million for Q2 2026 at Chemours, down from $69.0 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $69.0 million in Q1 2026, with the low at $40.0 million in Q2 2022.
• Average Non Operating Interest Expenses over 5 years is $57.8 million, with a median of $64.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses declined 16.33% in 2022, then surged 57.5% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $40.0 million in 2022, then soared by 57.5% to $63.0 million in 2023, then grew by 6.35% to $67.0 million in 2024, then rose by 1.49% to $68.0 million in 2025, then changed by 0.0% to $68.0 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $68.0 million (Q2 2026), $69.0 million (Q1 2026), and $68.0 million (Q4 2025), per Business Quant data.